Rewrite Therapeutics

Rewrite Therapeutics is a private biotechnology company focused on advancing novel DNA writing technologies. Rewrite has developed promising new tools for genome editing, including DNA writing via CRISPR/Cas9-guided polymerases. Rewrite has also devised a method to enhance the efficiency of genome editing in non-dividing cell types, a key challenge faced by some existing editing platforms.